1 / 56

Non-neoplastic intestinal disease Malabsorption Paul L. Crotty Department of Pathology

Non-neoplastic intestinal disease Malabsorption Paul L. Crotty Department of Pathology Tallaght Hospital October 2007. Outline of lecture. Review normal digestion/absorption How diseases interfere with the process Tests for malabsorption Coeliac disease Chronic pancreatitis

loman
Download Presentation

Non-neoplastic intestinal disease Malabsorption Paul L. Crotty Department of Pathology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Non-neoplastic intestinal disease Malabsorption Paul L. Crotty Department of Pathology Tallaght Hospital October 2007

  2. Outline of lecture • Review normal digestion/absorption • How diseases interfere with the process • Tests for malabsorption • Coeliac disease • Chronic pancreatitis • Bacterial overgrowth

  3. Malabsorption/Maldigestion • diverse disease processes • final common pathway of interference with normal digestion and absorption of nutrients • similar/overlapping clinical presentations • understanding normal digestion and absorption is central to understanding diseases that interfere with same

  4. Normal digestion and absorption • (1) Luminal phase • (2) Mucosal phase • (3) Removal phase

  5. As example: Triglycerides • Luminal phase: in small intestine • Pancreatic lipase: enzymatic hydrolysis into mono-acyl glycerol and free fatty acids • Solubilisation: incorporation into micelles with bile salts • Mucosal phase: in enterocyte cytoplasm • assembly into chylomicra with apoproteins • Removal phase: in lymphatics

  6. Normal process of fat digestion and absorption

  7. Diseases interfering with luminal phase • Pancreatic exocrine insufficiency • chronic pancreatitis • Bile salt deficiency • liver disease, especially cholestatic • bacterial overgrowth • terminal ileal disease • Other: post-gastrectomy, Zollinger-Ellison

  8. Diseases interfering with mucosal phase • Small bowel disease • Coeliac disease • Tropical sprue • Whipple’s disease • Crohn’s disease • Post-small bowel resection • Specific enzyme deficiency,transport protein defects, abetalipoproteinaemia

  9. Diseases interfering with removal phase • Lymphatic blockage • Primary lymphangiectasia • Obstruction

  10. Major disease entities • Coeliac disease • Chronic pancreatitis • Bacterial overgrowth

  11. Consequences of malabsorption • Effects of excess fat in stool • Steatorrhoea: bulky, pale, foul-smelling • Nutrient deficiencies: global/specific • Energy, Protein (failure to thrive, short stature, weight loss) • Specific deficiencies esp. fat soluble vitamins A, D, E and K, also iron

  12. Quantitation of fat in stool • Normal stool fat <6g/day (over range of dietary fat from 60 to 200g) • With diarrhoea of any cause: stool fat can rise up to 14g/day • With fat malabsorption: stool fat much higher: 50-100g/day range • Standard: 3-5 day collection

  13. D-xylose test • 5 carbon sugar: absorbed by passive diffusion • D-xylose test is a measure of functional surface area of small bowel • After overnight fast: 25g D-xylose given p.o • Measure serum level at 1h (normal >20mg/dl) • 5h urine collection (normal >4g) • FP: incomplete collection/dehydration/renal disease

  14. What do you expect the result of a D-xylose test will be in… • Chronic pancreatitis? • Coeliac disease? • Cholestatic liver disease? • Bacterial overgrowth?

  15. Key role of duodenal biopsy • Biopsy diagnosis of specific diseases • Giardia infestation, Whipple’s disease • abetalipoproteinaemia, lymphangiectasia • Significantly blunted villi or flat mucosa (partial or complete villous atrophy) • classically seen in untreated coeliac disease • but can also be seen in other food allergies, rarely in viral infection, Crohn’s disease, tropical sprue • Normal mucosa

  16. Patient with malabsorption with a normal duodenal biopsy • Any disease interfering with luminal phase of absorption • chronic pancreatitis • bile salt deficiency • ...but also in any primary small bowel disease with focal involvement

  17. 17 centuries later...

  18. 1950: Paulley identified villous abnormality Later shown that the histological abnormality normalised after gluten withdrawal and recurred after gluten challenge

  19. Alpha-Gliadin

  20. Alpha-GLIADIN PEPTIDES (SYNTHETIC) FOR WHICHTHERE IS IN VIVO EVIDENCE OF ACTIVITY

  21. Ingestion of gluten (or alpha-gliadin or even synthetic peptides) by a patient with coeliac disease causes symptoms in few hours and villous abnormality in 8-12 hours Why are gliadins toxic in some patients and not in others?

  22. Genetic factors • First degree relatives: 10% risk • MZ twin concordance: 70-90% • HLA-identical sibs: 30-50% concordance • In Europe: Coeliac patients >95% HLA-DQ2+ (vs. 25% in non-coeliacs) • >99% of DQ2+ individuals do not have coeliac disease • But significant component of genetic risk is accounted for by other non-HLA genes

  23. Immunological factors • Increased immunoglobulin production in small intestine • Most have circulating antibodies to alpha-gliadin • ...but is this cause or an effect of the disease ? • Antibodies to alpha-gliadin also seen in other intestinal diseases • Other circulating antibodies also found in coeliacs

  24. Current hypothesis • T-cell-mediated immunity of primary importance in pathogenesis • Increased intraepithelial CD8+ T lymphocytes • Increased CD4+ T lymphocytes in lamina propria • Evidence of T-cell activation

  25. Theory of pathogenesis • In a patient with a genetic predisposition... • Some initial trigger? • Adenoviral infection early in life?? • Immune response including presence of T cells with specific ability to respond to alpha-gliadin peptides

  26. Theory of pathogenesis • So later when any gluten-containing food is ingested…. • Rapid T cell activation with Th1 pattern of cytokine release causing enterocyte apoptosis • Enterocyte apoptosis leads to villous blunting/flattening • Loss of surface area for absorption of nutrients clinically reflected as malabsorption

  27. Antibodies SensitivitySpecificity AGA IgA 89% 95% IgG 99% 86% EMA >95% >95% tTG (IgA/IgG) >95% >95% IgA tests negative in the 2-3% of coeliacs with IgA deficiency

  28. Presentation • Any age: failure to thrive/short stature/wt loss • Steatorrhoea, fat-soluble vitamin deficiency • Diagnosis based on: • Clinical suspicion • Endoscopy with biopsy • Serology: circulating antibodies • Response to gluten withdrawal

  29. Complications • Long term effects of malabsorption: chronic vitamin deficiencies • Refractory sprue, ulcerative jejunoileitis, enteropathy-associated T cell lymphoma: all stages in a monoclonal lymphoid proliferation/lymphoma • Controversial whether there is a small increase in risk of carcinoma or not • dermatitis herpetiformis

  30. Dermatitis herpetiformis

  31. Chronic pancreatitis

  32. Exocrine pancreas • Pancreatic secretions: 2-3 litres/day • Secretion co-ordinated with presence of food in duodenum (via intestinal CCK) • Proteases (trypsin, chymotrypsin, aminpeptidase) • Pancreatic amylase • Pancreatic lipases

  33. How does pancreas protect itself from self-digestion? • Secreted as inactive pro-enzymes compartmentalised in granules • Activation of pro-enzymes requires presence of activated trypsin • Duodenal-derived enterokinase is required to activate trypsin • Pancreas also secretes trypsin inhibitors

  34. Pancreatitis • Acute (mild to severe necrotising/haemorrhagic) • Chronic (result of repeated episodes of mild acute pancreatitis) • Main causes: Alcohol, Gallstone disease • Other: medications, trauma, hypercalcaemia, hyperlipidaemia, post-instrumentation, blockage of duct by parasites or tumour

  35. Pathogenesis of pancreatitis • Gallstone disease: Duct obstruction • Alcohol: • ? Directly toxic to pancreas • ? Altered secretions: leads to plugging of duct • ? Sphincter of Oddi: alternate spasm/relaxation • In both: pancreatic self-destruction by enzymes • If chronic: scarring and loss of exocrine function

  36. Tests of pancreatic function • Direct measure of enzymes in duodenal aspirate • Indirect tests: • Bentiromide test: NBT-PABA bond cleaved by chymotrypsin: measure urinary PABA metabolites • Pancrealauryl test: Fluorescein dilaurate cleaved by pancreatic arylesterase: detect fluorescein in urine

More Related